Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
IL-2 Infusion in AML Patients After Autologous Bone Marrow Transplant: A Pediatric Oncology Group Wide Phase I Trial
3 other identifiers
interventional
1
6 countries
119
Brief Summary
RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill more cancer cells. PURPOSE: Phase I trial to study the effectiveness of interleukin-2 in treating children who have undergone bone marrow transplantation for acute myeloid leukemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 leukemia
Started Mar 1998
Longer than P75 for phase_1 leukemia
119 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 1998
CompletedFirst Submitted
Initial submission to the registry
February 2, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2001
CompletedFirst Posted
Study publicly available on registry
December 31, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedJune 28, 2013
June 1, 2013
3.3 years
February 2, 2001
June 27, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine the maximum tolerated dose (MTD) of IL-2
2 years
Study Arms (1)
All patients
EXPERIMENTALDay 1 through day 7, days 9-14 and days 16-22: The assigned dose of IL-2 will be administered SQ. On days 8 and 15, IL-2 will be administered as a 2 hour intravenous infusion of one million units/M2 of IL-2. After day 22 there will be a 7 day rest period before beginning the next cycle. The next cycle will repeat just as above. This will be repeated for a maximum of 4 total cycles of 21 days of IL-2 therapy. The maintenance dose of IL-2 will always be the same as given during cycle one, unless there is dose limiting toxicity.
Interventions
Given SQ and IV
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Children's Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (119)
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, 35294-3300, United States
University of South Alabama Medical Center
Mobile, Alabama, 36617-2293, United States
MBCCOP - Gulf Coast
Mobile, Alabama, 36688, United States
Arizona Cancer Center
Tucson, Arizona, 85724, United States
Arkansas Children's Hospital
Little Rock, Arkansas, 72202-3591, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
University of California San Diego Cancer Center
La Jolla, California, 92093-0658, United States
Lucile Packard Children's Hospital at Stanford
Palo Alto, California, 94304, United States
Sutter Cancer Center
Sacramento, California, 95816, United States
University of California Davis Medical Center
Sacramento, California, 95817, United States
Kaiser Permanente-Southern California Permanente Medical Group
San Diego, California, 92120, United States
Children's Hospital and Health Center
San Diego, California, 92123-4282, United States
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, 95051-5386, United States
Yale Comprehensive Cancer Center
New Haven, Connecticut, 06520-8028, United States
Walter Reed Army Medical Center
Washington D.C., District of Columbia, 20307-5000, United States
Broward General Medical Center
Fort Lauderdale, Florida, 33316, United States
Children's Hospital of Southwest Florida
Fort Myers, Florida, 33908, United States
Shands Hospital and Clinics, University of Florida
Gainesville, Florida, 32610-100277, United States
Nemours Children's Clinic
Jacksonville, Florida, 32207, United States
Sylvester Cancer Center, University of Miami
Miami, Florida, 33136, United States
University of Miami-Jackson Memorial Hospital Medical Center
Miami, Florida, 33136, United States
Miami Children's Hospital
Miami, Florida, 33155, United States
Baptist Hospital of Miami
Miami, Florida, 33176-2197, United States
Walt Disney Memorial Cancer Institute
Orlando, Florida, 32803, United States
All Children's Hospital
St. Petersburg, Florida, 33701, United States
CCOP - Florida Pediatric
Tampa, Florida, 33682-7757, United States
St. Mary's Hospital
West Palm Beach, Florida, 33407, United States
Emory University Hospital - Atlanta
Atlanta, Georgia, 30322, United States
Cancer Research Center of Hawaii
Honolulu, Hawaii, 96813, United States
Tripler Army Medical Center
Honolulu, Hawaii, 96859-5000, United States
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois, 60612, United States
Children's Memorial Hospital, Chicago
Chicago, Illinois, 60614, United States
Hope Children's Hospital
Oak Lawn, Illinois, 60453, United States
CCOP - Illinois Oncology Research Association
Peoria, Illinois, 61602, United States
Saint Jude Midwest Affiliate
Peoria, Illinois, 61637, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160-7357, United States
CCOP - Wichita
Wichita, Kansas, 67214-3882, United States
Via Christi Regional Medical Center
Wichita, Kansas, 67214, United States
MBCCOP - LSU Health Sciences Center
New Orleans, Louisiana, 70112, United States
Tulane University School of Medicine
New Orleans, Louisiana, 70112, United States
CCOP - Ochsner
New Orleans, Louisiana, 70121, United States
Eastern Maine Medical Center
Bangor, Maine, 04401, United States
Maine Children's Cancer Program
Portland, Maine, 04101, United States
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Baltimore, Maryland, 21201, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-2410, United States
Boston Floating Hospital Infants and Children
Boston, Massachusetts, 02111, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, 01655, United States
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
St. John's Hospital and Medical Center
Detroit, Michigan, 48236, United States
Hurley Medical Center
Flint, Michigan, 48503, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505, United States
Keesler Medical Center - Keesler AFB
Keesler Air Force Base, Mississippi, 39534-2576, United States
University of Missouri-Columbia Hospital and Clinics
Columbia, Missouri, 65212, United States
Cardinal Glennon Children's Hospital
St Louis, Missouri, 63104, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Norris Cotton Cancer Center
Lebanon, New Hampshire, 03756-0002, United States
CCOP - Northern New Jersey
Hackensack, New Jersey, 07601, United States
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
University of New Mexico School of Medicine
Albuquerque, New Mexico, 87131, United States
Roswell Park Cancer Institute
Buffalo, New York, 14263-0001, United States
Schneider Children's Hospital
New Hyde Park, New York, 11042, United States
Mount Sinai School of Medicine
New York, New York, 10029, United States
University of Rochester Cancer Center
Rochester, New York, 14642, United States
State University of New York Health Sciences Center - Stony Brook
Stony Brook, New York, 11790-7775, United States
State University of New York - Upstate Medical University
Syracuse, New York, 13210, United States
Mission Saint Joseph's Health System
Asheville, North Carolina, 28801, United States
Carolinas Medical Center
Charlotte, North Carolina, 28232-2861, United States
Presbyterian Healthcare
Charlotte, North Carolina, 28233-3549, United States
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710, United States
East Carolina University School of Medicine
Greenville, North Carolina, 27858-4354, United States
Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, 27157-1082, United States
Oklahoma Memorial Hospital
Oklahoma City, Oklahoma, 73126-0307, United States
Natalie Warren Bryant Cancer Center
Tulsa, Oklahoma, 74136, United States
CCOP - Columbia River Program
Portland, Oregon, 97213, United States
Legacy Emanuel Hospital and Health Center
Portland, Oregon, 97227, United States
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania, 19134-1095, United States
Medical University of South Carolina
Charleston, South Carolina, 29425-0721, United States
Children's Hospital of Greenville Hospital System
Greenville, South Carolina, 29605, United States
James H. Quillen College of Medicine
Johnson City, Tennessee, 37614-0622, United States
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105-2794, United States
Driscoll Children's Hospital
Corpus Christi, Texas, 78466, United States
Texas Oncology P.A.
Dallas, Texas, 75230-2503, United States
Medical City Dallas Hospital
Dallas, Texas, 75230, United States
Simmons Cancer Center - Dallas
Dallas, Texas, 75235-9154, United States
Cook Children's Medical Center - Fort Worth
Fort Worth, Texas, 76104, United States
University of Texas Medical Branch
Galveston, Texas, 77555-0209, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
San Antonio Military Pediatric Cancer and Blood Disorders Center
Lackland Air Force Base, Texas, 78236-5300, United States
MBCCOP - South Texas Pediatric
San Antonio, Texas, 78229-3900, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78284-7811, United States
Scott and White Clinic
Temple, Texas, 76508, United States
Vermont Cancer Center
Burlington, Vermont, 05401-3498, United States
Cancer Center at the University of Virginia
Charlottesville, Virginia, 22908, United States
Inova Fairfax Hospital
Falls Church, Virginia, 22042-3300, United States
Naval Medical Center, Portsmouth
Portsmouth, Virginia, 23708-2197, United States
Massey Cancer Center
Richmond, Virginia, 23298-0037, United States
Carilion Roanoke Community Hospital
Roanoke, Virginia, 24029, United States
Madigan Army Medical Center
Tacoma, Washington, 98431-5000, United States
West Virginia University Medical School-Charleston
Charleston, West Virginia, 25304, United States
West Virginia University Hospitals
Morgantown, West Virginia, 26506-9300, United States
St. Vincent Hospital
Green Bay, Wisconsin, 54307-3508, United States
Midwest Children's Cancer Center
Milwaukee, Wisconsin, 53226, United States
Royal Children's Hospital
Parkville, Victoria, 3052, Australia
Alberta Children's Hospital
Calgary, Alberta, T2T 5C7, Canada
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
Children's Hospital
Hamilton, Ontario, L8N 3Z5, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
McGill University Health Center - Montreal Children's Hospital
Montreal, Quebec, H3H 1P3, Canada
Hopital Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Laval University Medical Center
Sainte-Foy, Quebec, G1V 4G2, Canada
Centre Hospitalier de L'Universite Laval
Sainte-Foy, Quebec, GIV 4G2, Canada
Academisch Ziekenhuis Groningen
Groningen, 9713 EZ, Netherlands
San Jorge Childrens Hospital
Santurce, 00912, Puerto Rico
Swiss Pediatric Oncology Group Bern
Bern, CH 3010, Switzerland
Clinique de Pediatrie
Geneva, 1211, Switzerland
Centre Hospitalier Universitaire Vaudois
Lausanne, CH-1011, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Kimo C. Stine, MD
Arkansas Children's Hospital at the University of Arkansas for Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2001
First Posted
December 31, 2003
Study Start
March 1, 1998
Primary Completion
June 1, 2001
Study Completion
September 1, 2005
Last Updated
June 28, 2013
Record last verified: 2013-06